Abstract:Abstract To understand how microRNAs (miRNAs) regulate breast cancer tumorigenesis, a miRNA expression microarray screening was performed using RNAs from formalin-fixed paraffin-embedded (FFPE) breast tissues, which included benign (n=13), ductal carcinoma in situ (DCIS) (n=16), and invasive ductal carcinoma (IDC) (n=15). Twenty miRNAs that were differentially expressed (p<0.01) were identified, of which let-7 family miRNAs were down-regulated in human breast cancer tissues at stages of DCIS and IDC compared to benign stage. To understand the role of let-7 miRNAs further, we performed bioinformatics analysis and found that let-7 miRNA sequences match sequences in the 3’-UTRs of estrogen receptor alpha 66 (ER-α66) and another novel receptor ER-α36. The targeting of let-7 miRNAs on ER-α66 and ER-α36 was further confirmed by a number of experimental assays, including luciferase assay, protein expression, and mRNA expression. Overexpression of let-7 miRNAs in ER-α66-positive breast cancer MCF7 cell line negatively affected ER-α66 mediated genomic estrogen pathway. As expected, down-regulation of the ER-α66 signaling by let-7 miRNAs inhibited cell proliferation, and subsequently triggered the cell apoptotic process in MCF7 cells. On the other hand, overexpression of let-7 miRNAs in ER-α66-negative cell line MB-MDA-231 negatively affected ER-α36 mediated non-genomic estrogen pathway. Besides, down-regulation of let-7 is correlated with up-regulation of ER-α36 in tamoxifen (Tam) and ICI-182780 (ICI) resistance in MCF7 cell line. Forced overexpression in Tam-and ICI-resistant MCF7 cells dampened ER-α36 expression. In conclusion, our findings not only indicate a new regulatory mechanism of let-7 miRNAs in ER mediated cellular malignant growth of breast cancer, and but also provide potential biomarkers and/or surrogate therapeutic targets useful for early diagnosis and/or therapeutic options for breast cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 2025.

Reduced Let-7a is Associated with Chemoresistance in Primary Breast Cancer.

Advances in Research of Let-7 in Cancer

Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer

Pivotal Role Of Reduced Let-7g Expression In Breast Cancer Invasion And Metastasis

Data from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Let-7 Micrornas Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor Α Signaling in Breast Cancer.

Let-7 Inverts the Chemoresistance of Breast Tumor-Initiating Cells.

Abstract 2025: Let-7 Family Mirnas Regulate Estrogen Signaling Pathways Mediated by ER Alpha-66 and ER Alpha-36 in Breast Cancer

Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer

Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5

Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma.

MicroRNA Let-7C-5p Alleviates in Hepatocellular Carcinoma by Targeting Enhancer of Zeste Homolog 2: A Study Intersecting Bioinformatic Analysis and Validated Experiments

Microrna Microarray Identifies Let-7i As A Novel Biomarker And Therapeutic Target In Human Epithelial Ovarian Cancer

Lin28 Mediates Paclitaxel Resistance By Modulating P21, Rb And Let-7a Mirna In Breast Cancer Cells

Downregulation of microRNA let-7f mediated the Adriamycin resistance in leukemia cell line

Upregulation of Let-7F-5p Promotes Chemotherapeutic Resistance in Colorectal Cancer by Directly Repressing Several Pro-Apoptotic Proteins.

Let-7: a Regulator of the ERα Signaling Pathway in Human Breast Tumors and Breast Cancer Stem Cells.

Let-7c Sensitizes Acquired Cisplatin-Resistant A549 Cells by Targeting Abcc2 and Bcl-Xl

Let-7c Blocks Estrogen-Activated Wnt Signaling in Induction of Self-Renewal of Breast Cancer Stem Cells.

Let-7f and Mirna-126 Correlate with Reduced Cardiotoxicity Risk in Triple-Negative Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy.

Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking